Nasdaq Qualification. The Shares to be issued shall be duly authorized for listing by Nasdaq, subject to official notice of issuance, to the extent required by the rules of Nasdaq.
Appears in 30 contracts
Sources: Securities Purchase Agreement (GENELUX Corp), Securities Purchase Agreement (Tracon Pharmaceuticals, Inc.), Securities Purchase Agreement (Regulus Therapeutics Inc.)
Nasdaq Qualification. The Shares to be issued shall be duly authorized for listing by Nasdaq, subject to official notice of issuance, to the extent required by the rules of Nasdaq.
Appears in 22 contracts
Sources: Securities Purchase Agreement (Tracon Pharmaceuticals, Inc.), Securities Purchase Agreement (Stratasys Ltd.), Securities Purchase Agreement (Yuma Regional Medical Center)
Nasdaq Qualification. The Shares to be issued and the Warrant Shares shall be duly authorized for listing by Nasdaq, subject to official notice of issuance, to the extent required by the rules of Nasdaq.
Appears in 4 contracts
Sources: Securities Purchase Agreement (Inhibrx, Inc.), Securities Purchase Agreement (Taysha Gene Therapies, Inc.), Securities Purchase Agreement (UroGen Pharma Ltd.)
Nasdaq Qualification. The Shares to be issued shall be duly authorized for listing by NasdaqThe Nasdaq National Market, subject to official notice of issuance, to the extent required by the rules of NasdaqThe Nasdaq National Market.
Appears in 4 contracts
Sources: Share Purchase Agreement (Penwest Pharmaceuticals Co), Share Purchase Agreement (TRM Corp), Securities Purchase Agreement (Penwest Pharmaceuticals Co)
Nasdaq Qualification. The Shares to be issued shall be duly authorized for listing by NasdaqThe Nasdaq National Market, subject to official notice of issuance, to the extent required by the rules of NasdaqThe Nasdaq National Market.
Appears in 4 contracts
Sources: Share Purchase Agreement (Penwest Pharmaceuticals Co), Share Purchase Agreement (TRM Corp), Securities Purchase Agreement (Penwest Pharmaceuticals Co)
Nasdaq Qualification. The Shares to be issued shall will be duly authorized for listing by Nasdaq, subject to official notice of issuance, to the extent required by the rules of Nasdaq.
Appears in 3 contracts
Sources: Stock Purchase Agreement (Foghorn Therapeutics Inc.), Stock Purchase Agreement (Homology Medicines, Inc.), Stock Purchase Agreement (Ionis Pharmaceuticals Inc)
Nasdaq Qualification. The Shares to be issued shall be duly authorized for listing by Nasdaq, subject to official notice of issuance, to the extent required by the listing rules of Nasdaq.
Appears in 2 contracts
Sources: Securities Purchase Agreement (ARCA Biopharma, Inc.), Securities Purchase Agreement (ARCA Biopharma, Inc.)
Nasdaq Qualification. The Common Shares to be issued and the Conversion Shares shall be duly authorized for listing by Nasdaq, subject to official notice of issuance, to the extent required by the rules of Nasdaq.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Regulus Therapeutics Inc.), Securities Purchase Agreement (Regulus Therapeutics Inc.)
Nasdaq Qualification. The Common Shares, Warrant Shares and Conversion Shares to be issued shall be duly authorized for listing by Nasdaq, subject to official notice of issuance, to the extent required by the rules of Nasdaq.
Appears in 1 contract
Nasdaq Qualification. The Common Shares, Common Warrant Shares and Pre-Funded Warrant Shares to be issued shall be duly authorized for listing by Nasdaq, subject to official notice of issuance, to the extent required by the rules of Nasdaq.
Appears in 1 contract
Sources: Securities Purchase Agreement (Anebulo Pharmaceuticals, Inc.)
Nasdaq Qualification. The Shares to be issued shall be duly authorized for listing by Nasdaq, subject to official notice of issuance, to the extent required by the rules of Nasdaq.
Appears in 1 contract
Sources: Securities Purchase Agreement (Tracon Pharmaceuticals, Inc.)
Nasdaq Qualification. The Shares to be issued and the Warrant Shares shall be duly authorized for listing by Nasdaq, subject to official notice of issuance, to the extent required by the rules of Nasdaq.
Appears in 1 contract
Nasdaq Qualification. The Shares to be issued shall will be duly authorized for listing by Nasdaq, subject to official notice of issuance, to the extent required by the rules of Nasdaq..
Appears in 1 contract
Sources: Stock Purchase Agreement (Coherus BioSciences, Inc.)
Nasdaq Qualification. The Shares and the Warrant Shares to be issued shall be duly authorized for listing by Nasdaq, subject to official notice of issuance, to the extent required by the rules of Nasdaq.
Appears in 1 contract
Nasdaq Qualification. The Shares to be issued shall will be duly authorized for listing by Nasdaq, subject to official notice of issuance, to the extent required by the rules of Nasdaq.
Appears in 1 contract
Sources: License and Research Agreement (Isis Pharmaceuticals Inc)
Nasdaq Qualification. The Shares and the Warrant Shares to be issued shall be duly authorized for listing by Nasdaq, subject to official notice of issuance, to the extent required by the rules of Nasdaq.
Appears in 1 contract